Статьи, помеченные тэгом ‘treatment of genetic diseases’

Genzyme Corporation (NASDAQ: GENZ) catches a bullish trend

Tuesday, August 3rd, 2010

Genzyme Corporation (NASDAQ: GENZ) stayed in the green area at around 70.36 yesterday. Genzyme Co shares gained +0.80 (1.15%). Pre-market today: 71.88 +1.52 (2.16%). The good news are supporting the bulls.

(more…)